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    Abstract.      Antibody (IgG) responses to the saliva of   Phlebotomus argentipes   were investigated using serum samples 
from regions of India endemic and non-endemic for visceral leishmaniasis (VL). By pre-adsorbing the sera against the 
saliva of the competing human-biting but non-VL vector   P. papatasi  , we significantly improved the specificity of a   P. argen-
tipes   saliva enzyme-linked immunosorbent assay. Using this method, we observed a statistically significant correlation 
between antibodies to   P. argenitpes   saliva and the average indoor density of female sand flies. Additionally, the method 
was able to detect recent changes in vector exposure when sera from VL patients were assayed before, during, and after 
hospitalization and protected from sand fly bites under untreated bed nets. Collectively, these results highlight the utility 
of antibodies to   P. argentipes   saliva as an important tool to evaluate VL vector control programs.     
    INTRODUCTION 
  Visceral leishmaniasis (VL) in the Indian subcontinent, 
also known as kala-azar, is caused by   Leishmania donovani . 
The disease is fatal if not treated, and VL is responsible for 
an estimated 60,000 deaths per year worldwide.  1   The  annual 
incidence of kala-azar cases is estimated to be 0.5 million 
and the prevalence to be 2.5 million.  1   More than 90% of the 
world’s reported VL cases are in India, Nepal, Bangladesh, 
Sudan, and Brazil. In India the main endemic focus is in Bihar 
State where resistance to the first-line treatment, pentava-
lent antimonials, is rife; there is no vaccine.  2   In India, Nepal, 
and Bangladesh,   L. donovani   is transmitted exclusively by 
  Phlebotomus argentipes  , a sand fly that is considered anthro-
ponotic.  3,4   Because VL in the Indian subcontinent cycles pre-
dominantly between humans, with no established zoonotic 
involvement, control strategies have focused on prevention of 
infection through the promotion of early diagnosis and vector 
control.  5,6  
  Currently, one of the biggest limitations to the evalua-
tion of vector control programs is the accurate estimation of 
exposure to vector bites and transmission. Traditional meth-
ods rely heavily upon efficient trapping of vectors, and tech-
niques such as human landing studies are now considered 
unethical for measuring protection in regions of endemic-
ity.  7,8   Field studies using enzyme-linked immunosorbent assay 
(ELISA) techniques have demonstrated the presence of anti-
bodies to sand fly saliva in humans,  9–12   foxes, and dogs  12   nat-
urally exposed to sand fly bites. Accordingly, these findings 
have stimulated interest in the use of antibodies against sand 
fly saliva as a diagnostic tool for evaluating exposure and/
or risk of infection among humans living in areas endemic 
for leishmaniasis. However, the utility of a sand fly saliva 
ELISA has not been formally demonstrated in human popu-
lations in VL foci. The vector specificity of the technique and 
its sensitivity to reflect levels of exposure in humans has not 
been addressed. Furthermore, basic information on the per-
sistence of human antibodies against sand fly saliva in the 
field is unknown. This is particularly important if the tech-
nique is to be used to estimate recent histories of sand fly 
bite. 
  The aim of this study was to investigate the potential util-
ity of a novel   P .   argentipes   saliva ELISA to estimate recent 
exposure of human populations to sand fly bite, and to obtain 
much needed information on the kinetics of human antibody 
responses to this important VL vector. 
   MATERIALS AND  METHODS 
  Study  population.     We tested 240 serum samples that were 
divided into five main groups: 1) 62 samples from healthy 
persons living in a rural VL-endemic foci of Bihar state, India; 
2) 27 healthy Indian controls from urban, non-VL areas 
of Western Uttar Pradesh (Indian non-endemic controls 
[NECs]); 3) 12 samples from residents in the United Kingdom 
with no history of travel to India, Nepal, or Bangladesh (UK 
NECs); 4) 52 VL patients with active kala-azar from Bihar 
(  L. donovani -positive by spleen biopsy) re-sampled after their 
30-day treatment in a hospital and 16 of these re-sampled 
patients six months after discharge from a hospital; and 
5) 87 Indian and Nepalese samples from control households 
of the KALANET Long Lasting Insecticide Bed Net study 
(ClinicalTrials.gov CT-2005-015374) in which untreated bed 
nets were used. 
 Serum samples used in the study were obtained from patients 
≥ 15 years of age (India and Nepal: age range = 15–62 years, 
median = 30 years; UK: age range = 21–35 years, median = 24 
years). Patients with VL were treated with either amphoteri-
cin B or paromomycin and confined to the Kala-Azar Medical 
Research Center in Muzzafarpur, Bihar State. During this 
time, they were protected from additional sand fly bites by the 802 CLEMENTS AND OTHERS
personal use of untreated bed nets in a hospital that routinely 
sprays their grounds with insecticides. Ethical clearance for 
the study was obtained from the institutional review boards of 
B. P. Koirala Institute of Health Sciences, Dharan, Nepal, and 
the Institute of Medical Sciences, Banaras Hindu University, 
India. Written informed consent was obtained from all study 
participants and their households. 
   Sand  fly  survey.     The abundance of sand flies was estimated 
for 15 and 16 months in households in Nepal and India, 
respectively. Twenty-five houses were randomly selected from 
each of five control clusters (three in India and two in Nepal) 
of the KALANET project in which there was no prior history 
or current use of bed nets. Each house was sampled for one 
night in September 2006 for   P .   argentipes   by aspiration, and 
10 households from each cluster with the highest sand fly 
density were selected for a complete entomologic survey. For 
each survey, a CDC light trap (Miniature Incandescent Light 
Trap Model 1012; J.W. Hock Company, Gainesville, FL) was 
used. Collection was performed during one night per month 
(6:00   pm   to 6:00   am  ) from September 2006 to November 
and December 2007 in Nepal and India, respectively. One 
CDC light trap per house was installed typically near the 
corner of a bedroom situated 15 cm above the ground and 
3 cm away from the wall. Collected sand flies were sexed 
and speciated under a binocular microscope. Geometric 
means of female   P .   argentipes   sand flies were calculated per 
household (aggregate = 15 months) to evaluate the in-house 
density  (as a proxy for exposure to sand flies). Sera from 
permanent adult occupants were collected from each household 
during November–December 2007 at the end of entomologic 
monitoring. 
   Sand  fly  saliva  preparation.     Saliva from colonized   P . 
  argentipes   (Rajendra Memorial Research Institute, Patna, 
India, and Keele University, Keele, United Kingdom) or 
  P .   papatasi   (Charles University, Prague, Czech Republic) was 
collected from female flies five days old post-emergence and 
maintained on 70% sucrose solution given   ad libitum .  Pools 
of 10 sand fly salivary gland pairs were collected in 50 μL 
of phosphate-buffered saline (PBS) on ice and individually 
pierced to release their saliva. After centrifugation (1,800 ×   g  
for 5 minutes), the saliva was collected from the supernatant 
fraction, leaving behind the salivary gland epithelia and other 
sand fly debris. Aliquots of saliva from 50 flies were collected, 
pooled, and frozen at −70°C until used. For transportation to 
the field, saliva was lyophilized and reconstituted in its original 
volume of distilled water for one hour at room temperature 
before use. 
      Serologic analysis of antibodies against saliva.    Total 
specific IgG against saliva was measured by ELISA. All 
chemicals and reagents were obtained from Sigma (Irving, 
United Kingdom) unless otherwise stated. Microtiter plates 
(Maxisorb; Nunc, Roskilde, Denmark) were coated with 
50 μL of 50 ng of   P .   papatasi   saliva in 0.01 M carbonate-
bicarbonate buffer, pH 9.6, overnight at 4°C. The wells were 
washed four times with 200 μL of PBS buffer containing 
0.05% Tween 20 (PBS-Tween) and blocked with 200 μL 
of 5% bovine serum albumin (BSA) in PBS-Tween for 
2 hours at 37°C. After washing, 100 μL of human sera were 
diluted 1:50 in PBS-Tween and incubated in duplicate 
overnight at 4°C (pre-adsorption step). In parallel, new plates 
were coated with 50 μL of 50 ng of   P .   argentipes   saliva as 
described above and incubated over  night at 4°C without 
shaking. After washing and blocking of the   P. argentipes -
coated plates, sera were transferred from the   P .   papatasi  
plates to the   P .   argentipes   plates and incubated for 2 hours 
at 37°C. The   P .   papatasi   plates were washed, filled with 
200  μL of wash buffer, sealed with parafilm, and kept 
at 4°C for 2 hours, thus enabling sufficient time for the 
  P .   argentipes   and   P .   papatasi   plates to reach the same point 
in the protocol and be processed together for the rest of the 
assay. One hundred microliters of biotinylated anti-human 
IgG was added at a dilution of 1:2,000 in PBS-Tween to all 
plates and incubated for 1 hour at 25°C. The plates were 
then washed and incubated with 100 μL of streptavidin-
conjugated alkaline phosphatase at a dilution of 1:1,000. One 
hundred microliters of paranitrophenylphosphate (1 mg/mL) 
diluted in substrate buffer (carbonate-bicarbonate buffer 
with 10% diethanolamine and 3 mM MgCl  2  , pH 9.6) was 
added as a substrate and the absorbance of the yellow product 
was measured at 405 nm using a Spectramax 190 ELISA plate 
reader (Molecular Devices, Sunnyvale, CA) after 20 minutes 
of color development at 25°C in the dark. The cut-off value 
was set at two standard deviations from the mean of the 
Indian non-endemic control group. 
   Antibody half-life.   The half-life of antibodies against salivary 
in patients was determined from VL hospitalization study data 
by using the equation half life (in days) = elapsed time × log  2 /
log (average day 0 titer/average day 30 titer). 
   Statistical  analysis.     The ELISA data were not normally 
distributed. Therefore, the Mann-Whitney test was used to 
compare means using the Prism version 5 software (GraphPad 
Software, San Diego, CA). Correlations were tested by using 
the Spearman rank correlation coefficient. For those paired 
data in which patients were assayed over time, a Wilcoxon 
matched pairs test was used. A   P   value  < 0.05 was considered 
significant. 
    RESULTS 
  To investigate whether a human population from an 
leishmaniasis-endemic region had IgG against salivary gland 
antigens of the vector sand fly   P .   argentipes  , we measured by 
ELISA the antibody level in sera of 89 adults from India and 
12 adults from the United Kingdom. Analysis showed a high 
level of antibodies against   P .   argentipes   saliva in persons from 
India compared with persons from the United Kingdom (  P   < 
0.0001) (  Figure 1A    ). The indirect ELISA used in all similar 
sand fly saliva studies to date did not detect any differences 
in antibody levels between non-endemic and leishmaniasis-
endemic regions of India (  P   = 0.756) (  Figure 1A  ). Only 24% 
(12 of 50) of persons from disease-endemic regions had val-
ues greater than the two standard deviation cut-off value com-
pared with the Indian NEC group. 
  To investigate whether cross-reactive antigens to the com-
peting human-biting sand fly   P .   papatasi   interfered with 
the   P .   argentiptes   ELISA, we re-examined the sera with a 
  P .   papatasi   saliva ELISA. This test confirmed the presence of 
antibodies to saliva of this sand fly; 36% (18 of 50) of sera 
of persons from leishmaniasis-endemic regions had IgG lev-
els greater than those of the non-endemic control cut-off 
value (  P   = 0.0004) (  Figure 1B  ). Moreover, a positive corre-
lation between IgG levels against the saliva from both these 
human-biting sand flies was present in persons in India from 803 SALIVA-ELISA FOR DETECTION OF P. ARGENTIPES BITES
 F igure   1.       Human IgG response to   Phlebotomus argentipes   and   P. papatasi   saliva. Comparison of United Kingdom (open triangles, n = 12) and 
Indian non-endemic control (NEC) (open circles, unadsorbed, n = 25 and pre-adsorbed, n = 27) sera against sera from an area of India endemic 
for visceral leishmaniasis (VL) (filled diamonds, unadsorbed, n = 52 and pre-adsorbed, n = 62). Sera were processed for antibodies to   P. argentipes  
(  A  ) and   P. papatasi   ( B  ) saliva by using a standard indirect enzyme-linked immunosorbent assay (ELISA) format. (  C  ) Levels of antibodies against 
  P. argentipes   saliva by modified ELISA with a   P. papatasi   saliva pre-adsorption step. (  D  ) Correlation between   P. argentipes   and   P. papatasi   saliva 
antibody responses from the Indian VL-exposed cohort. Bars in dot plots represent the median value of the groups. Lines represent cut-off values 
two standard deviations from the mean of the NEC group. Asterisks indicate statistical significance between the groups indicated (ns = not signifi-
cant; ***  P   <  0.0005).    
VL-endemic areas ( P  < 0.0001, Spearman r = 0.71) ( Figure 1D ). 
These data suggest that persons from VL-endemic regions 
are being bitten by   P .   papatasi   and   P .   argentipes   to a similar 
extent. 
  To improve the specificity of the ELISA for detection of 
  P .   argentipes  , we tested the utility of a serum pre-adsorption 
step against   P .   papatasi   saliva. Re-examination of the human 
sera with the modified   P .   argentipes   ELISA method (  Figure 
1C  ) resulted in a greater degree of separation between the 
non-endemic and disease-endemic groups from India (  P   < 
0.0001), with 82% (51 of 62) of sera from persons from VL-
endemic regions above the cut-off value. 
  To test the ability of the   P .   argentipes   saliva ELISA to 
measure sand fly exposure in the field, we conducted ento-
mologic surveys of 28 households in India and 15 house-
holds in Nepal in VL-endemic foci. Using the   P .   papatasi  
pre-adsorbed saliva ELISA, we observed a significant 
logarithmic correlation between the antibody responses 
against   P .   argentipes   saliva in sera from persons in India 
and Nepal sera and the 15-month geometric average num-
ber of indoor female   P .   argentipes   trapped per household 
(Spearman r = 0.44,   P   = 0.0007) (  Figure 2    ). A similar result 
was also found with antibodies against   P .   papatasi   saliva 
(Spearman r = 0.44,   P   < 0.0001, data not shown). Analysis of 804 CLEMENTS AND OTHERS
individual clusters for geometric mean peak sand fly den-
sities (recorded during October and November 2006) and 
saliva antibody responses confirmed that there was no bias 
between clusters (Supplementary Table 1, available at   www
.ajtmh.org ). 
  To be considered a useful tool for measurement of recent 
exposure to sand fly bites, the antibody response of humans 
to sand fly saliva needs to be transient. To observe the kinetics 
of antibody responses against   P .   argentipes   saliva in humans 
during vector intervention, we monitored VL patients 
immediately before hospitalization (day 0), at the end of 
their course of drug treatment (day 30), and six months after 
their discharge (day 180) (  Figure 3    ). During hospitalization, 
patients were screened from additional sand fly bites by the 
use of untreated bed nets. Despite the wide variation, using 
the pre-adsorbed saliva ELISA, we found that the median 
antibody titers to   P .   argentipes   saliva decreased during their 
stay in a hospital (day 0 versus day 30:  P  = 0.010) ( Figure 3A ). 
However, antibody levels then increased to greater than pre-
hospitalization levels by six months after discharge (day 30 
versus day 180,   P .   argentipes ;   P   < 0.0001). Pairwise analy-
sis of 16 sera for which all three time points were collected 
(  Figure 3B  ) confirmed a decrease in individual saliva anti-
bodies when persons slept under untreated bed nets (day 0 
versus day 30;   P   = 0.0007). A similar response was also seen 
for antibody levels against   P .   papatasi   saliva, with a moder-
ate decrease from day 0 to day 30 (  P   = 0.19), followed by 
a significant increase after release from a hospital (  P   = 
0.001). From these data, we calculated that for people in 
India, half-life of IgG against   P .   argentipes   saliva is approxi-
mately 166 days. 
   DISCUSSION 
  We report the human antibody response to saliva of   P . 
  argentipes  , the vector of VL in the Indian sub-continent. In 
human populations from VL-endemic areas, we found that 
levels of IgG reflect differences in sand fly exposure. 
  Sand fly saliva is a complex mixture of pharmacologically 
active compounds whose combined function is to help the 
sand fly obtain blood during a bite. This saliva is known to 
contain a variety of anti-hemostatic, vasodilatory, and immu-
nomodulatory compounds.  13   Therefore, saliva will always be 
present during a bite from either an uninfected or infected 
sand fly. Sand fly saliva is also highly immunogenic,  9–12,14   and 
antibodies against saliva of specific sand fly vectors have 
been valued as potential tools for measurement of commu-
nity or personal exposure to sand fly bites by ELISA and risk 
of   Leishmania   infection. The complexity of sand fly saliva is 
such that different species, and perhaps sibling species, of sand 
flies contain specific antigens,  14,15   which reinforce the utility 
of this approach. It is expected that any salivary antigen used 
for this purpose should be 1) specific for the bite of the vec-
tor species in question, 2) sensitive enough to use as a mea-
sure of relative exposure, and 3) exhibit low persistence in 
the host to accurately reflect changes in vector exposure with 
time. 
  Our pre-adsorbed   P .   argentipes   saliva ELISA could dis-
tinguish persons from a sand fly–free country (United 
Kingdom) or persons from urban areas of India where VL 
is rarely reported from those sera collected from persons in 
the VL-endemic State of Bihar, India. Pre-adsorption also 
enhanced the ability of the ELISA to distinguish between the 
Indian non-endemic control and VL endemic groups. The exact 
reason for this finding is unknown, but one explanation may 
be the result of the presence of   P .   papatasi   and absence (or 
much lower frequency) of   P. argentipes   sand flies in the NEC 
region of Western Uttar Pradesh. More in depth entomologic 
surveying of Indian NEC regions are required to address this 
possibility. In India,   P .   argentipes   and   P .   papatasi   are the most 
frequent human-biting sand flies. Exploratory experiments 
using mice bitten by either   P .   papatasi   or   P .   argentipes   col-
onized sand flies showed that cross-reactive antibodies exist 
and that inclusion of a   P .   papatasi   saliva pre-adsorption step 
significantly reduced their contribution in an ELISA for detec-
tion of antibodies against   P .   argentipes   saliva (Hostomska J, 
Volf P, Rogers MR, unpublished data). Using this assay with 
 F igure   2.       Correlation of human IgG levels to   Phlebotomus argen-
tipes   saliva with indoor sand fly densities. Forty-three Indian and 
Nepalese households from five control clusters were surveyed for 
15 months for densities of   P. argentipes  . Sand flies were sampled 
overnight by using CDC light traps. At the end of the survey, sera 
from all residents (n = 87) was collected, assayed for antibodies against 
  P. argentipes   saliva by using the   P. papatasi   pre-adsorbed enzyme-
linked immunosorbent assay method and compared with average 
peak season   P. argentipes   indoor  densities.    805 SALIVA-ELISA FOR DETECTION OF P. ARGENTIPES BITES
human sera, we significantly reduced levels of cross-reactive 
antibodies against saliva between these sand fly species and 
vastly improved the specificity of the ELISA towards the VL 
vector. In addition, a useful byproduct of the pre-adsorption 
method is the ability to measure the antibody response to the 
competing sand fly species (  P .   papatasi ) .  
  To test the sensitivity of the   P .   argentipes   saliva ELISA 
to reflect differing amounts of exposure to this sand fly, we 
surveyed households in India and Nepal for the number of 
  P. argentipes   and   P .   papatasi   present over a 15–16-month 
period. Houses were selected from control clusters of the 
KALANET program in which no insecticide-treated bed nets 
were used. This survey showed that the average household 
sand fly densities of   P .   argentipes   and   P .   papatasi   showed a 
strong correlation with the antibody response of the residents 
to these endophilic and endophagic sand flies. It appears that 
the sensitivity of the assay is reduced when the   P .   papatasi  
saliva pre-adsorption step was included, as shown by the Indian 
NEC group. However, the overall benefit of this modification 
is the increased its specificity towards the VL vector. The spec-
ificity and sensitivity of the assay may be further improved if 
whole   P .   argentipes   saliva could be replaced by recombinant 
antigen(s) that have been screened for their ability to reflect 
specific exposure to this fly bite. Because this approach will 
 F igure   3.       Decrease in human IgG levels to   Phlebotomus argentipes   saliva after vector intervention.   A  , Sera were analyzed for antibodies against 
the saliva of   P. argentipes   (using the   P. papatasi   pre-adsorbed enzyme-linked immunosorbent assay method) from patients with visceral leishmania-
sis taken at the point of diagnosis (open circles), after their 30-day treatment in hospital (open triangles) and 6 months after their discharge (open 
diamonds) (n = 52). During their stay in the hospital, patients were protected from further exposure from sand fly bites with untreated bed nets. 
  B  , Paired antibody levels for a subsample of 16 patients. Bars represent the median value of the groups. Asterisks indicate statistical significance 
between the groups indicated (ns = not significant; *  P   < 0.05; **  P   < 0.005; ***  P   <  0.0005).    806 CLEMENTS AND OTHERS
not require labor-intensive sand fly rearing and salivary gland 
dissection, this modification will make the assay more ame-
nable for large-scale application. 
  Finally, we addressed the ability of antibodies against   P . 
  argentipes   saliva to identify recent periods of non-exposure 
to sand fly bites. Such a tool would only have value for moni-
toring vector control measures that reduce sand fly contact 
rates for humans if antibody titers are transient and increase 
relatively quickly after re-exposure. This potential use has 
been observed for mosquito and tick salivary antigens in 
humans  16,17   and triatomine salivary antigens in mice.  18   To 
our knowledge, no studies have tested the kinetics of anti-
bodies in humans against sand fly saliva from the field, but 
laboratory experiments with naive dogs exposed to the bites 
of the sand fly   Lutzomyia longipalpis   have found significant 
decreases in IgG against sand fly saliva and IgG2 titers within 
weeks after exposure.  19   In the present study, we show that 
VL patients hospitalized and protected from sand fly bite 
by untreated bed nets was corroborated by an average 15% 
reduction of antibody titers against  P .  argentipes  after 30 days. 
Upon discharge from hospitals, antibody levels against saliva 
in these patients increased significantly beyond their origi-
nal pre-treatment levels after six months re-exposure to bites. 
This finding indicates a classic antibody memory response to 
saliva of both species of sand flies. 
  Thus, the   P .   argentipes   saliva ELISA is likely to be useful in 
understanding the epidemiology of VL. For example,   L. don-
ovani   has been identified in the blood of domesticated ani-
mals sampled from VL-endemic regions of Nepal (Dujardin 
JC, unpublished data), and the saliva ELISA could help inves-
tigate this possible zoonotic cycle of transmission. A study in 
children in Brazil in whom antibodies against   Lutzomyia lon-
gipalpis   sand fly saliva developed showed that they were more 
likely to resist zoonotic VL caused by   L .   infantum chagasi . 9,10  
Whether a similar effect occurs between   P .   argentipes   saliva 
and   L .   donovani   infection in the Indian subcontinent remains 
to be tested but the assay we describe should be instrumental 
in these studies. 
  The novel saliva ELISA we describe is a significant step 
towards determining the communal (and eventually personal) 
level of   P .   argentipes   exposure in human populations at risk 
for VL. After validation on a larger scale, this method will 
improve evaluation of vector control programs and enable 
investigation of new aspects of the epidemiology of this 
neglected tropical disease. 
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